| Sur un cas d'agrypnie (4 mois sans sommeil) au cours d'une maladie de Morvan. Effet favorable du 5-hydroxytryptophane |
| C. Fischer-Perroudon, J. Mouret et M. Jouvet Electroencephalography and Clinical Neurophysiology, 1974, 36: 1-18 |
| IMPRESSION |
| Version imprimable (Tout l'article dans une seule page) |
Tableau I
Duration (in minutes) of total sleep time (TST), stage I, II, III, IV and paradoxical sleep (SP) for standard nightly recording time of 720 min.
A: During the control period (March 1970).
B: During the administration of placebos (May 1970).
C: During the administration of L-tryptophan (12 g per diem) (May
1970).
D,E: During the administration of small dose of DL-5-HTP (less
than 2 g per diem) (April and May 1970).
The mean and S.E.M. are given for each period.